InsiderClue
Insiders · Profile

Karas Eric

Chief Commercial Officer at ARS Pharmaceuticals. Filing since 19 Aug 2024. CIK 0001951287

Company
Date
Role
Action
Shares
Amount
Of holding
SPRY ARS Pharmaceuticals, Inc.
12 Jun 2026
Chief Commercial Officer
Sold on a plan
25,000
$250.00K
67.2%
SPRY ARS Pharmaceuticals, Inc.
1 Jul 2025
Chief Commercial Officer
Sold on a plan
15,000
$254.86K
59.3%
SPRY ARS Pharmaceuticals, Inc.
18 Jun 2025
Chief Commercial Officer
Sold on a plan
15,000
$240.00K
66.1%
SPRY ARS Pharmaceuticals, Inc.
20 Mar 2025
Chief Commercial Officer
Sold on a plan
10,000
$140.00K
56.5%
SPRY ARS Pharmaceuticals, Inc.
4 Dec 2024
Chief Commercial Officer
Sold on a plan
6,283
$87.96K
52.5%
SPRY ARS Pharmaceuticals, Inc.
2 Dec 2024
Chief Commercial Officer
Sold on a plan
3,717
$52.46K
39.5%
SPRY ARS Pharmaceuticals, Inc.
18 Sep 2024
Chief Commercial Officer
Sold on a plan
10,000
$140.00K
63.7%
SPRY ARS Pharmaceuticals, Inc.
19 Aug 2024
Chief Commercial Officer
Sold on a plan
10,000
$140.00K
63.7%
8 decisions on file.